Key result
Vascular closure devices achieved hemostasis more rapidly than standard care in patients undergoing atrial fibrillation ablation.
Why the study?
Despite potential benefits, concerns remain regarding time to hemostasis, time to discharge, and vascular complications with vascular closure devices compared to standard care in patients undergoing AF ablation.
Meta-Analysis (n=30,560)
Answers are grounded in this paper and cite their sources.
Systematic review and meta-analysis compare vascular closure devices to standard care in atrial fibrillation treatment, indicating potential benefits.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Farid et al. (2026) conducted a meta-analysis in Atrial fibrillation undergoing ablation (n=30,560). Vascular closure devices (VCDs) vs. Standard care (SC) was evaluated on Time to hemostasis (MD -5.63 min, 95% CI -7.30 to -3.95, p=< 0.01). Vascular closure devices achieved hemostasis more rapidly than standard care in patients undergoing atrial fibrillation ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: